Biological Mimetics, Inc.
Privately held biomedical company (founded 1996) focused on vaccine design and point-of-care diagnostics. Core activities include computational epitope prediction and immune-refocusing for antigen design, development of UVC-based pathogen inactivation for inactivated vaccines, and low-resource microfluidic CRISPR/RPA diagnostic devices. The organization conducts preclinical development, collaborates with academic and government partners, and pursues grant-funded research.
Industries
N/A
Products
Power-free funnel-adapted sensing tube for nucleic acid detection
Disposable multi-chambered microfluidic device enabling pipette-free sample processing and sequential reactions (disruption, RPA, CRISPR cleavage) with visual or camera-based readout.
UVC inactivation vaccine platform with manganese-peptide complex
Inactivated vaccine platform that complexes pathogens with a manganese-peptide-phosphate formulation prior to UVC irradiation to produce inactivated vaccine candidates intended for IND-enabling development.
Ellipsometry-based rapid bacterial identification platform
Optical, label-free biosensing approach under development to rapidly identify bacterial infections for clinical decision support in emergency and rapid clinic settings.
Power-free funnel-adapted sensing tube for nucleic acid detection
Disposable multi-chambered microfluidic device enabling pipette-free sample processing and sequential reactions (disruption, RPA, CRISPR cleavage) with visual or camera-based readout.
UVC inactivation vaccine platform with manganese-peptide complex
Inactivated vaccine platform that complexes pathogens with a manganese-peptide-phosphate formulation prior to UVC irradiation to produce inactivated vaccine candidates intended for IND-enabling development.
Ellipsometry-based rapid bacterial identification platform
Optical, label-free biosensing approach under development to rapidly identify bacterial infections for clinical decision support in emergency and rapid clinic settings.
Services
Collaborative R&D and partnership programs
Research collaborations, sponsored projects, and partnerships to advance vaccines and diagnostics from prototype to deployment.
Assay development and beta testing for low-resource diagnostics
Design, prototyping, and beta-testing support for power-free, instrument-free nucleic acid diagnostic devices and reagents.
Preclinical manufacturing and IND-enabling support
Production of GLP/GMP-like lots for animal safety and efficacy studies and preparation of regulatory documentation for IND submissions.
Collaborative R&D and partnership programs
Research collaborations, sponsored projects, and partnerships to advance vaccines and diagnostics from prototype to deployment.
Assay development and beta testing for low-resource diagnostics
Design, prototyping, and beta-testing support for power-free, instrument-free nucleic acid diagnostic devices and reagents.
Preclinical manufacturing and IND-enabling support
Production of GLP/GMP-like lots for animal safety and efficacy studies and preparation of regulatory documentation for IND submissions.
Expertise Areas
- Vaccine design and preclinical development
- Point-of-care nucleic acid diagnostics
- Immunoinformatics and epitope engineering
- CRISPR-based molecular detection
Key Technologies
- CRISPR-based diagnostics (Cas12a/Cas13-type detection)
- Recombinase polymerase amplification (RPA)
- Microfluidic multi-chamber devices
- PVA sacrificial-core chip fabrication